...
首页> 外文期刊>Journal of neurology >Rhabdomyolysis induced by severe levodopa induced dyskinesia in a patient with Parkinson's disease.
【24h】

Rhabdomyolysis induced by severe levodopa induced dyskinesia in a patient with Parkinson's disease.

机译:严重左旋多巴引起的横纹肌溶解引起帕金森氏病患者的运动障碍。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A 74-year-old man with Parkinson's disease (PD) who had been regularly taking levodopa for 17 years developed severe generalized dyskinesia of choreiform movement. He began to show bradykinesia and rigidity in right limbs *at age 57 years. Levodopa treatment dramatically improved his parkinsonian symptoms. Three years after levodopa treatment, he began to feel wearing-off. At age 72 years, he suffered from levodopa-induced dyskinesia (LID) during levodopa on period and was immobile during the off period. Seven days before his first visit to emergency room, he began to feel deterioration of his symptoms with levodopa/ carbidopa 250/25 mg q.i.d. and controlled-release form of levodopa/benserazide 100/25 mg q.i.d. Although peak dose dyskinesia gradually worsened, he gradually increased the dosage until he was taking 12 tablets of levodopa/carbi-dopa 250/25 mg and four tablets of levodopa/benserazide 100/25 mg per day.
机译:一名74岁的帕金森氏病(PD)患者,他定期服用左旋多巴达17年,出现严重的全身性舞蹈样运动障碍。他57岁时开始表现出右肢运动迟缓和僵硬。左旋多巴的治疗显着改善了帕金森病症状。左旋多巴治疗三年后,他开始感到疲倦。在72岁时,他在左旋多巴的服药期间患有左旋多巴诱发的运动障碍(LID),而在停药期则无法活动。首次访问急诊室前七天,他开始服用左旋多巴/卡比多巴250/25毫克q.i.d.开始感到症状恶化。左旋多巴/苄丝肼的控释形式100/25 mg q.i.d.尽管峰值剂量运动障碍逐渐加重,但他逐渐增加剂量,直到每天服用12片左旋多巴/卡比多巴250/25 mg和四片左旋多巴/苄丝肼100/25 mg。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号